VERA
Vera Therapeutics Inc
NASDAQ: VERA · HEALTHCARE · BIOTECHNOLOGY
$35.84
-3.42% today
Updated 2026-04-29
Market cap
$2.57B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.66
Dividend yield
—
52W range
$19 – $56
Volume
1.2M
Vera Therapeutics Inc (VERA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | $5.38M | $54.55M | $83.75M | $131.44M | $175.55M | $655.68M |
| Cash & equivalents | $3.19M | $53.65M | $79.67M | $43.46M | $45.68M | $92.65M |
| Current assets | $3.56M | $54.26M | $82.54M | $125.70M | $172.02M | $651.22M |
| Total liabilities | $41.93M | $143.90M | $14.16M | $54.53M | $73.86M | $78.53M |
| Current liabilities | $1.06M | $2.41M | $7.69M | $25.60M | $22.30M | $25.37M |
| Long-term debt | — | — | $4.92M | $24.81M | $49.88M | $50.69M |
| Shareholder equity | $-36.55M | $-89.35M | $69.59M | $76.91M | $101.69M | $577.15M |
| Retained earnings | $-38.03M | $-91.45M | $-124.06M | $-213.11M | $-309.10M | $-461.25M |
| Accounts receivable | — | $52000.00 | — | — | — | $3.77M |
| Inventory | — | $472000.00 | — | — | — | — |
| Goodwill | — | — | — | — | — | — |